By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab automation company Tecan and ForteBio have partnered to integrate their liquid handling and robotics workstation technologies to provide label-free assays for use in drug discovery and bioprocess research.

The companies have worked together to integrate ForteBio's Octet 384 platform, which includes the RED 384 and the QK384, on Tecan's Freedom EVO liquid handling workstation, Tecan said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.